Health Care Costs Associated With Muscle Weakness: A UK Population-Based Estimate.

ABSTRACT: Sarcopenia and muscle weakness are responsible for considerable health care expenditure but little is known about these costs in the UK. To address this, we estimated the excess economic burden for individuals with muscle weakness regarding the provision of health and social care among 442 men and women (aged 71-80 years) who participated in the Hertfordshire Cohort Study (UK). Muscle weakness, characterised by low grip strength, was defined according to the Foundation for the National Institutes of Health criteria (men < 26 kg, women < 16 kg). Costs associated with primary care consultations and visits, outpatient and inpatient secondary care, medications, and formal (paid) as well as informal care for each participant were calculated. Mean total costs per person and their corresponding c

SUBMITTER: Pinedo-Villanueva R 

PROVIDER: S-EPMC6330088 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature